Dr. med. univ. Roswitha Köberle-Wührer

Koeberle-Wuehrer R, Haid A, Sprenger-Maehr H, Koeberle D, Meusburger E, Neyer U. Intraoperative blood sampling for parathyroid hormone measurement during total parathyroidectomy and autotransplantation in patients with renal hyperparathyroidism. 
Wien Klin Wochenschr. 1999 Mar 26;111(6):246-50

Haid A, Fritzsche H, Peschina W, Gruber-Mösenbacher U, Jasarevic S, Hillbrand E, Müller G, Köberle-Wührer R, Schmidle T, Breitfellner G.
Sentinel node biopsy in breast-cancer—a minimally invasive procedure for staging of the axilla
Wien Klin Wochenschr. 1999 Mar 26;111(6):219-25.

Haid A, Köberle-Wührer R, Knauer M, Burtscher J, Fritzsche H, Peschina W, Jasarevic Z, Ammann M, Hergan K, Sturn H, Zimmermann G.
Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation
Breast Cancer Res Treat. 2002 May;73(1):31-6.

Haid A, Koeberle-Wuehrer R, Offner F, Jasarevic Z, Fritzsche H, Zimmermann G. 
Clinical usefulness and perspectives of sentinel node biopsy in the management of breast cancer.
Chirurg. 2003 Jul;74(7):657-64
Haid A, Knauer M, Köberle-Wührer R, Wenzl E
Sentinel node biopsy in breast cancer: techniques and indications 
Wien Klin Wochenschr. 2005 Feb;117(4):121-8.

Haid A, Knauer M, Köberle-Wührer R, Ammann K, Koller L, Eiter H, Lang A, Wenzl E.
Medium-term follow-up data after sentinel node biopsy alone for breast cancer.
Eur J Surg Oncol. 2006 Dec;32(10):1180-5. Epub 2006 Jun 5.

Konstantiniuk P, Schrenk P, Reitsamer R, Koeberle-Wuehrer R, Tausch C, Roka S, Riedl O, Poestlberger S, Hecke D, Janauer M, Haid A. 
A nonrandomized follow-up comparison between standard axillary node dissection and sentinel node biopsy in breast cancer.
Breast. 2007 Oct;16(5):520-6

Knauer M, Haid A, Schneider Y, Köberle-Wührer R, Lang A, Winder T, Alton R, Jasarevic Z, Säly C, Offner FA, Wenzl E, deVries A.
Adjuvant extension of chemotheray after neoadjuvant therapy may not improve outcome in early-stage breast cancer.
Eur J Surg Oncol. 2009 Aug;35(8):798-804

Hillenbrand A, Varhaug JE, Brauckhoff M, Pandev R, Haufe S, Dotzenrath C, Köberle R, Hoffmann R, Klein G, Kadmon M, Negele T, Hagieva T, Henne-Bruns D, Luster M, Weber T. 
Familial nonmedullary thyroid carcinoma-clinical relevance and prognosis. A European multicenter study. ESES Vienna presentation.
Langenbecks Arch Surg. 2010 Sep;395(7):851-8

Köberle R., Falconier-Benedik,
Primärer Hyperparathyreoidismus
Ther Umsch. 2020 Nov;77(9):433-440. 

Rosenberg R, Köberle R, Becker PM, Meienberg F. 
Nebennierentumore
Ther Umsch. 2020 Nov;77(9):441-448.

Carneiro-Pla D, Koeberle-Wuehrer R, Solorzano Cc, 
Hypercalcemic crisis. Endocrine Surgery Comprehensive Board Exam Guide A.L. Shifrin et al (eds) 989-1011, Springer Nature Switzerland AG 2021

Staubitz JI, Elmrich I, Musholt PB, Cámara RJA, Watzka F, Dralle H, Sekulla C, Lorenz K, Musholt TJ; Targeted use of intraoperative frozen-section analysis lowers the frequency of completion thyroidectomy.
Prospective Evaluation Study Thyroid Surgery (PETS) 2 study group.
BJS Open. 2021 Mar 5;5(2):zraa058.

Clerici T, Kolb W, Beutner U, Bareck E, Dotzenrath C, Kull C, Niederle B; German Association of Endocrine Surgeons. Diagnosis and treatment of small follicular thyroid carcinomas
Br J Surg. 2010 Jun;97(6):839-44.

Gnant M, Pfeiler G, Dubsky PC, Hubalek M, Greil R, Jakesz R, Wette V, Balic M, Haslbauer F, Melbinger E, Bjelic-Radisic V, Artner-Matuschek S, Fitzal F, Marth C, Sevelda P, Mlineritsch B, Steger GG, Manfreda D, Exner R, Egle D, Bergh J, Kainberger F, Talbot S, Warner D, Fesl C, Singer CF; Austrian Breast and Colorectal Cancer Study Group.
Adjuvant denusomab in breast cancer(ABCSG-18): a multicenter, randomized, double-blind, placebo-controled trial
Lancet. 2015 Aug 1;386(9992):433-43 Engl J Med. 2009 Feb 12;360(7):679-91.

Gnant M, Mlineritsch B, Schippinger W, Luschin-Ebengreuth G, Pöstlberger S, Menzel C, Jakesz R, Seifert M, Hubalek M, Bjelic-Radisic V, Samonigg H, Tausch C, Eidtmann H, Steger G, Kwasny W, Dubsky P, Fridrik M, Fitzal F, Stierer M, Rücklinger E, Greil R; ABCSG-12 Trial Investigators; Marth C.
Endocrine Therapy plus zolendronic acid in premenopausal breast cancer
N Engl J Med. 2009 Feb 12;360(7):679-91 

Gnant M, Mlineritsch B, Luschin-Ebengreuth G, Kainberger F, Kässmann H, Piswanger-Sölkner JC, Seifert M, Ploner F, Menzel C, Dubsky P, Fitzal F, Bjelic-Radisic V, Steger G, Greil R, Marth C, Kubista E, Samonigg H, Wohlmuth P, Mittlböck M, Jakesz R; Austrian Breast and Colorectal Cancer Study Group (ABCSG).
Adjuvant endocrine Therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone mineral density substudy
Lancet Oncol. 2008 Sep;9(9):840-9.Lancet Oncol. 2008 Sep;9(9):840-9.

Dubsky P, Sevelda P, Jakesz R, Hausmaninger H, Samonigg H, Seifert M, Denison U, Mlineritsch B, Steger G, Kwasny W, Stöger H, Bartsch R, Stierer M, Taucher S, Fridrik M, Schippinger W, Greil R, Pötter R, Gnant M; Austrian Breast and Colorectal Cancer Study Group.
Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamite /methotrexate/5-fluorouracil chemotherapy
Clin Cancer Res. 2008 Apr 1;14(7):2082-7.